- 4.4Impact Factor
- 8.8CiteScore
- 21 daysTime to First Decision
Special Issues
Cancers publishes Special Issues to create collections of papers on specific topics, with the aim of building a community of authors and readers to discuss the latest research and develop new ideas and research directions. Special Issues are led by Guest Editors, who are experts on the topic and all Special Issue submissions follow MDPI's standard editorial process.
The journal’s Editor-in-Chief and/or designated Editorial Board Member will oversee Guest Editor appointments and Special Issue proposals, checking their content for relevance and ensuring the suitability of the material for the journal. The papers published in a Special Issue will be collected and displayed on a dedicated page of the journal’s website. Further information on MDPI's Special Issue polices and Guest Editor responsibilities can be found here. For any inquiries related to a Special Issue, please contact the Editorial Office.
Recent Advances in Liquid Biopsy Biomarkers of Cancer
Deadline: 15 July 2026
Integrating Chemotherapy and Immunotherapy for Head and Neck Cancer
Deadline: 15 July 2026
Tumor Microenvironment of Breast Cancer—2nd Edition
Deadline: 15 July 2026
Penile Cancer and Rare Urogenital Malignancies: From Biology to Clinical Management
Deadline: 15 July 2026
Advances in Hodgkin Lymphoma (HL)
Deadline: 15 July 2026
Pancreatic Cancer: Genomics, Therapy and Survival
Deadline: 15 July 2026
Robotic Versus Laparoscopic Surgery for Colorectal Cancer
Deadline: 15 July 2026
Thermal Ablation in the Management for Colorectal Liver Metastases: 2nd Edition
Deadline: 15 July 2026
Robotic and Laparoscopic Techniques for Urologic Cancers: Innovations in Resection and Reconstruction
Deadline: 15 July 2026
Myelodysplastic Neoplasms (MDS) and Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN): New Insights into Diagnosis and Targeted Therapy
Deadline: 15 July 2026
Radiologic Imaging of Hepatocellular Carcinomas
Deadline: 15 July 2026
Molecular Signatures of Therapy: Biomarkers Predicting Response and Relapse in Cancer
Deadline: 15 July 2026
of 261

